KVUE | tickerfilter.com

Fundamental analysis

39%

Profitability 30%

Dept financing 21%

Liquidity 25%

Performance 57%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0.30%

1 Month

12.07%

3 Months

5.24%

6 Months

1.78%

1 Year

16.63%

2 Year

-12.68%

Key data

Stock price

$23.49

P/E Ratio

39.68

DAY RANGE

$23.38 - $24.15

EPS

$0.54

52 WEEK RANGE

$17.67 - $24.46

52 WEEK CHANGE

$15.09

MARKET CAP

40.874 B

YIELD

3.80%

SHARES OUTSTANDING

1.915 B

DIVIDEND

$0.205

EX-DIVIDEND DATE

02-12-2025

NEXT EARNINGS DATE

N/A

BETA

-0.11

PUBLIC FLOAT

AVERAGE 10 VOLUME

$14,896,240

AVERAGE 30 VOLUME

$16,917,925

Company detail

CEO: Thibaut Mongon
Region: US
Website: www.jnj.com/kenvue/
Employees: 0
IPO year: 2023

Issue type: Common Stock
Market: NYSE
Industry: Consumer Goods/Perfumes, Cosmetics And Other Toilet Preparations
Sector: Manufacturing

We are the world’s largest pure-play consumer health company by revenue with $15.0 billion in net sales in 2022. We combine the power of science with meaningful human insights and digital-first capabilities, which we believe empowers approximately 1.2 billion people to live healthier lives every day. Prior to the completion of this offering, we are a wholly owned subsidiary of Johnson & Johnson. Our principal executive offices are located at 199 Grandview Road, Skillman, NJ.

KVUE - Kenvue Inc.